265 related articles for article (PubMed ID: 31480288)
1. The Impact of Hormonal Replacement Treatment in Postmenopausal Women with Uterine Fibroids: A State-of-the-Art Review of the Literature.
Moro E; Degli Esposti E; Borghese G; Manzara F; Zanello M; Raimondo D; Gava G; Arena A; Casadio P; Meriggiola MC; Seracchioli R
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31480288
[No Abstract] [Full Text] [Related]
2. The effects of hormone replacement therapy on uterine fibroids in postmenopausal women.
Sener AB; Seçkin NC; Ozmen S; Gökmen O; Doğu N; Ekici E
Fertil Steril; 1996 Feb; 65(2):354-7. PubMed ID: 8566261
[TBL] [Abstract][Full Text] [Related]
3. Effect of different doses of progestin on uterine leiomyomas in postmenopausal women.
Palomba S; Sena T; Morelli M; Noia R; Zullo F; Mastrantonio P
Eur J Obstet Gynecol Reprod Biol; 2002 May; 102(2):199-201. PubMed ID: 11950491
[TBL] [Abstract][Full Text] [Related]
4. The management of uterine leiomyomas.
Vilos GA; Allaire C; Laberge PY; Leyland N;
J Obstet Gynaecol Can; 2015 Feb; 37(2):157-178. PubMed ID: 25767949
[TBL] [Abstract][Full Text] [Related]
5. Effect of tibolone on postmenopausal women with myomas.
Gregoriou O; Vitoratos N; Papadias C; Konidaris S; Costomenos D; Chryssikopoulos A
Maturitas; 1997 Jun; 27(2):187-91. PubMed ID: 9255754
[TBL] [Abstract][Full Text] [Related]
6. Transdermal hormone replacement therapy in postmenopausal women with uterine leiomyomas.
Palomba S; Sena T; Noia R; Di Carlo C; Zullo F; Mastrantonio P
Obstet Gynecol; 2001 Dec; 98(6):1053-8. PubMed ID: 11755553
[TBL] [Abstract][Full Text] [Related]
7. Effect of hormone replacement therapy on uterine fibroids in postmenopausal women--a 3-year study.
Yang CH; Lee JN; Hsu SC; Kuo CH; Tsai EM
Maturitas; 2002 Sep; 43(1):35-9. PubMed ID: 12270580
[TBL] [Abstract][Full Text] [Related]
8. Hormonal Replacement Therapy in Menopausal Women with History of Endometriosis: A Review of Literature.
Zanello M; Borghese G; Manzara F; Degli Esposti E; Moro E; Raimondo D; Abdullahi LO; Arena A; Terzano P; Meriggiola MC; Seracchioli R
Medicina (Kaunas); 2019 Aug; 55(8):. PubMed ID: 31416164
[TBL] [Abstract][Full Text] [Related]
9. Effect of hormone replacement therapies and selective estrogen receptor modulators in postmenopausal women with uterine leiomyomas: a literature review.
Ang WC; Farrell E; Vollenhoven B
Climacteric; 2001 Dec; 4(4):284-92. PubMed ID: 11770184
[TBL] [Abstract][Full Text] [Related]
10. Impact of different hormone replacement therapy regimens on the size of myoma uteri in postmenopausal period: tibolone versus transdermal hormonal replacement system.
Simsek T; Karakus C; Trak B
Maturitas; 2002 Jul; 42(3):243-6. PubMed ID: 12161049
[TBL] [Abstract][Full Text] [Related]
11. Oestrogen and progestogen hormone replacement therapy for peri-menopausal and post-menopausal women: weight and body fat distribution.
Norman RJ; Flight IH; Rees MC
Cochrane Database Syst Rev; 2000; (2):CD001018. PubMed ID: 10796730
[TBL] [Abstract][Full Text] [Related]
12. Bleeding patterns in recent postmenopausal outpatients with uterine myomas: comparison between two regimens of HRT.
de Aloysio D; Altieri P; Penacchioni P; Salgarello M; Ventura V
Maturitas; 1998 Jun; 29(3):261-4. PubMed ID: 9699198
[TBL] [Abstract][Full Text] [Related]
13. Selective estrogen receptor modulators (SERMs) for uterine leiomyomas.
Deng L; Wu T; Chen XY; Xie L; Yang J
Cochrane Database Syst Rev; 2012 Oct; 10():CD005287. PubMed ID: 23076912
[TBL] [Abstract][Full Text] [Related]
14. [The effects of menopausal replacement therapy in women with uterine myomas].
Orsini G; Pinto V; Di Biase S; D'Altorio C; Lanzilotti G
Minerva Ginecol; 1999 Nov; 51(11):421-5. PubMed ID: 10726441
[TBL] [Abstract][Full Text] [Related]
15. Hormone therapy and venous thromboembolism.
Peverill RE
Best Pract Res Clin Endocrinol Metab; 2003 Mar; 17(1):149-64. PubMed ID: 12763518
[TBL] [Abstract][Full Text] [Related]
16. Uterine findings by transvaginal sonography during percutaneous estrogen treatment in postmenopausal women.
Ylöstalo P; Granberg S; Bäckström AC; Hirsjärvi-Lahti T
Maturitas; 1996 Apr; 23(3):313-7. PubMed ID: 8794426
[TBL] [Abstract][Full Text] [Related]
17. Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women.
Palomba S; Sammartino A; Di Carlo C; Affinito P; Zullo F; Nappi C
Fertil Steril; 2001 Jul; 76(1):38-43. PubMed ID: 11438317
[TBL] [Abstract][Full Text] [Related]
18. An evidence-based approach to hormonal therapies for premenopausal women with fibroids.
Lethaby AE; Vollenhoven BJ
Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):307-31. PubMed ID: 17905660
[TBL] [Abstract][Full Text] [Related]
19. A prospective, randomized trial of gonadotropin-releasing hormone agonist plus estrogen-progestin or progestin "add-back" regimens for women with leiomyomata uteri.
Friedman AJ; Daly M; Juneau-Norcross M; Rein MS; Fine C; Gleason R; Leboff M
J Clin Endocrinol Metab; 1993 Jun; 76(6):1439-45. PubMed ID: 8501148
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal estrogen and progestogen therapy and the risk of uterine leiomyomas.
Reed SD; Cushing-Haugen KL; Daling JR; Scholes D; Schwartz SM
Menopause; 2004; 11(2):214-22. PubMed ID: 15021452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
